
Sign up to save your podcasts
Or


Opill, the over-the-counter birth control pill recently approved by the FDA, marked a major win for access to contraceptives. But, in the wake of SCOTUS's Dobbs decision, some have called for codifying the right to contraceptive access in federal law. Dana Singiser, cofounder of the nonprofit Contraceptive Access Initiative and senior advisor to Americans For Contraception, talks with Stephanie Desmon about Opill, the overwhelming bipartisan voter support for contraception, and her work advocating for access as a federal right.
By The Johns Hopkins Bloomberg School of Public Health4.6
618618 ratings
Opill, the over-the-counter birth control pill recently approved by the FDA, marked a major win for access to contraceptives. But, in the wake of SCOTUS's Dobbs decision, some have called for codifying the right to contraceptive access in federal law. Dana Singiser, cofounder of the nonprofit Contraceptive Access Initiative and senior advisor to Americans For Contraception, talks with Stephanie Desmon about Opill, the overwhelming bipartisan voter support for contraception, and her work advocating for access as a federal right.

43,543 Listeners

40 Listeners

5 Listeners

27 Listeners

5 Listeners

262 Listeners

56,509 Listeners

494 Listeners

9 Listeners

45 Listeners

92 Listeners

16,353 Listeners

16 Listeners

4,753 Listeners

2 Listeners

4,486 Listeners

391 Listeners

6,552 Listeners

25 Listeners

6,384 Listeners

237 Listeners

65 Listeners

164 Listeners

98 Listeners